BioScrip Inc Stock Nasdaq
Equities
US09069N1081
Healthcare Facilities & Services
Financials (USD)
Sales 2024 * | 4.74B | Sales 2025 * | 5.16B | Capitalization | 5.09B |
---|---|---|---|---|---|
Net income 2024 * | 204M | Net income 2025 * | 233M | EV / Sales 2024 * | 1.21 x |
Net Debt 2024 * | 659M | Net Debt 2025 * | 350M | EV / Sales 2025 * | 1.06 x |
P/E ratio 2024 * |
25.2
x | P/E ratio 2025 * |
22.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.9% |
Latest transcript on BioScrip Inc
Managers | Title | Age | Since |
---|---|---|---|
John Rademacher
CEO | Chief Executive Officer | 57 | 19-08-05 |
Michael Shapiro
DFI | Director of Finance/CFO | 53 | 14-12-31 |
Caroline Budde
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Kraemer
CHM | Chairman | 69 | 19-08-06 |
David Golding
BRD | Director/Board Member | 62 | 15-04-30 |
John Arlotta
BRD | Director/Board Member | 74 | 19-08-06 |
1st Jan change | Capi. | |
---|---|---|
-14.73% | 84.87B | |
+16.05% | 83.08B | |
+10.92% | 29.4B | |
-12.73% | 16.72B | |
-3.74% | 16.4B | |
-1.78% | 15.04B | |
+0.08% | 11.88B | |
-31.58% | 11.86B | |
-5.12% | 11.88B |